U.S. Water Utilities Stock News

In recent days, multiple firms including Citigroup, CIBC, Bernstein, and J.P. Morgan have updated their views on Waste Connections ahead of its previously scheduled fourth-quarter 2025 earnings release and 2026 outlook call. This cluster of analyst updates underscores growing focus on how sector headwinds in recycling and pricing assumptions could influence Waste Connections’ upcoming guidance. Now we’ll examine how this recent wave of analyst reassessments ahead of earnings may affect...

Earlier this week, MSA Safety’s Board declared a first‑quarter 2026 dividend of US$0.53 per common share and US$0.5625 per preferred share, payable in March to shareholders of record on February 13, 2026. This announcement extends the company’s more than five‑decade record of uninterrupted dividends with over a decade of consecutive annual increases, underscoring its focus on consistent shareholder returns. Next, we’ll examine how MSA Safety’s continued dividend commitment influences its...

Visteon (VC) has been drawing investor attention after a recent stretch of mixed share performance, with the stock showing a 3.9% decline over the past day and a 6.2% decline over the past month. See our latest analysis for Visteon. At a share price of $93.69, Visteon’s recent 7 day and 90 day share price returns of 8.05% and 18.26% declines contrast with a 1 year total shareholder return of 12.06%. This suggests shorter term momentum has been fading while longer term holders have still come...

In recent days, HEICO reported past record profitability, broad-based revenue growth, and strong cash generation, underpinned by resilient aviation support demand and continued acquisitions. This combination of robust operating performance, disciplined deal-making, and strong returns on invested capital has reinforced perceptions of HEICO as a high-quality compounder in specialized aerospace and electronics markets. We’ll now examine how HEICO’s record profitability and strong cash...

Aveanna Healthcare Holdings (AVAH) raised its 2025 revenue guidance to a range of US$2.425b to US$2.445b and issued higher preliminary 2026 targets, putting its home based care model firmly in focus for investors. See our latest analysis for Aveanna Healthcare Holdings. Aveanna’s updated guidance comes after a mixed stretch in the market, with a 7 day share price return of 7.33% and a 90 day share price return of a 10.22% decline. Even so, the year to date share price return of 14.11% and a...

Landstar System recently announced that it released its fourth-quarter 2025 results on January 28, 2026, followed by a conference call with analysts and investors that same afternoon, with both live and replay access available through its investor relations website. Alongside this earnings communication, a broad group of research firms has reaffirmed coverage of Landstar while revisiting their expectations for the company’s longer-term business trajectory. We’ll explore how this cluster of...

Earlier in January, Cabot Corporation reported a multi-year agreement to supply advanced conductive carbons and dispersions to PowerCo SE for use in electric-vehicle battery electrodes, while also moving to rebalance its board by conditionally resetting director Thierry Vanlancker’s term at the 2026 Annual Meeting. This combination of a long-term EV battery materials partnership and board realignment highlights Cabot’s effort to strengthen its role across the global clean-energy value...

In the past few days, BofA Securities downgraded Taylor Morrison Home to Neutral from Buy, citing sector pressures from employment, inflation, and heightened competition that could weigh on the builder’s 2026 earnings. This reassessment contrasts with management’s earlier plans for over 100 new community openings in 2026 and targeted closings growth supported by ongoing share repurchases. Next, we’ll examine how BofA’s concerns over weaker 2026 home deliveries could reshape Taylor Morrison...

William Blair has started covering Enerpac Tool Group (EPAC) with a Market Perform rating, adding a fresh research voice just ahead of the company’s presentation at CJS Securities’ New Ideas for the New Year investor conference. See our latest analysis for Enerpac Tool Group. The William Blair initiation comes after a solid run in the past month, with a 30 day share price return of 9.32%. Over the past year there has been a 7.99% decline in total shareholder return, while the 3 year total...

Why CNO Financial Group Stock Is On Investors’ Radar CNO Financial Group (CNO) is drawing attention after recent trading left the shares with mixed short term returns but strong multi year total returns. This is prompting investors to reassess the insurer’s current valuation. See our latest analysis for CNO Financial Group. At a recent share price of US$41.54, CNO has seen weaker short term share price returns over the past month and year to date. Its one year and multi year total shareholder...

Earlier this month, Lamb Weston Holdings, Inc. confirmed it will close its Munro, Argentina plant, consolidating Latin American production into a newer Mar del Plata facility, while also temporarily curtailing a production line in the Netherlands and providing severance to about 100 affected employees. This manufacturing reshuffle highlights how Lamb Weston is reshaping its global footprint under its Focus to Win plan, with potential implications for cost efficiency, regional supply...

Victory Capital Holdings recently reported Total Client Assets of about US$316.60 billion as of December 31, 2025, alongside long-term Assets Under Management net outflows of US$2.10 billion in the fourth quarter, and it has already scheduled its fourth-quarter 2025 results release and conference call for early February 2026. This combination of broadly stable overall asset levels with continued long-term net outflows raises fresh questions about the strength and durability of the firm’s...

Earlier in January 2026, Oculis Holding announced that the FDA granted Breakthrough Therapy designation to its neuroprotective candidate Privosegtor for optic neuritis, while also outlining late-stage plans for Privosegtor and its eye-drop OCS-01 in diabetic macular edema. The move positions Oculis as a potential first-mover in neuroprotective treatments for optic neuropathies, a category the company estimates could exceed US$7.00 billion in the U.S. alone. We will now examine how FDA...

Targa Resources Corp. previously declared a quarterly cash dividend of US$1.00 per common share for the fourth quarter of 2025, payable on February 13, 2026, to shareholders of record as of January 30, 2026. The company also signaled an intention to recommend lifting its quarterly dividend to US$1.25 per share for the first quarter of 2026, underscoring management’s confidence in the durability of its fee-based cash flows. With this planned dividend increase signalling stronger cash return...

In recent days, multiple brokerages, including KeyBanc, Jefferies, UBS, and others, have upgraded or reinforced positive ratings on YETI Holdings, citing factors such as supply chain stabilization, international expansion, and resilient demand across coolers, bags, and drinkware. This clustering of supportive analyst views suggests growing institutional confidence in YETI’s business momentum, even as some firms remain cautious with Hold or Neutral recommendations. We’ll now explore how this...

JBS has exited its meat snacks joint venture with US jerky maker Jack Link’s, ending a partnership formed in 2010 and allowing Jack Link’s to assume full control of the Meat Snack Partners business after Brazilian regulators received a clearance request. This move points to a reshaping of JBS’s product mix and geographic exposure, as it steps back from Brazil-based meat snack production for export markets. We’ll now examine how JBS’s withdrawal from the Jack Link’s venture reframes its...

TSS (TSSI) drew fresh attention after CEO Darryll E. Dewan and CFO Daniel M. Chism presented at the 28th Annual Needham Growth Conference, giving institutional investors direct access to management and the company’s current positioning. See our latest analysis for TSS. The conference appearance comes at a time when momentum in TSS’s share price has picked up, with a 7 day share price return of 41.27% and a 30 day share price return of 59.60% following a weaker 90 day share price return of...

Perdoceo Education (PRDO) has completed a US$74.8 million share repurchase tranche and announced a new buyback authorization of up to US$100 million, drawing fresh attention to how its stock is being valued. See our latest analysis for Perdoceo Education. The buyback announcements come after a period of mixed share price momentum, with a 7.67% 1 month share price return and an 11.57% 3 month share price decline. Yet longer term total shareholder returns of 16.29% over 1 year and more than 2x...

Earlier in January 2026, Amylyx Pharmaceuticals announced it had selected AMX0318, a long-acting GLP-1 receptor antagonist discovered with Gubra A/S, as a development candidate for post-bariatric hypoglycemia and other rare diseases following extensive preclinical evaluation. The move expands Amylyx’s pipeline into GLP-1 biology and rare metabolic conditions, while triggering up to US$50 million in potential milestones and mid-single digit royalties to Gubra, including US$4 million tied to...

Hope Bancorp, Inc. recently amended and restated its bylaws as part of a periodic governance review, while long-serving director Scott Yoon-Suk Whang decided to retire from the boards of both the company and Bank of Hope following the 2026 Annual Meeting of Stockholders. Whang’s departure, combined with bylaw changes and a planned reduction of the board to nine members, marks a meaningful governance reset for the regional bank as it refines oversight, succession planning, and director...

Datwyler recently announced a collaboration with LTS Device Technologies and Stevanato Group to create a pre-verified large-volume subcutaneous drug delivery ecosystem, showcased at Pharmapack in Paris in January 2026. The partnership highlights how Stevanato’s EZ-fill large-volume cartridges can be integrated with advanced plungers and wearable devices to support at-home administration of sensitive therapies. We’ll now explore how this large-volume self-administration platform could...

Timken (TKR) has put leadership changes front and center by creating a chief technology officer role and reshaping regional presidencies. These moves are aimed at sharpening technology focus and aligning sales efforts across key global markets. See our latest analysis for Timken. Timken’s leadership refresh comes as the share price trades at $93.55, with a 30-day share price return of 9.72% and a 90-day share price return of 24.57%. The 1-year total shareholder return sits at 24.22%,...

Morgan Stanley recently downgraded American Assets Trust from Equalweight to Underweight, citing weak growth prospects, significant 2026–2027 lease expirations, refinancing challenges, and the risk of a future dividend reduction, while Mizuho highlighted broader shopping center REIT sector headwinds and occupancy saturation. This combination of company-specific concerns and broader sector caution has sharpened investor focus on American Assets Trust’s balance sheet flexibility, leasing risks...

PagerDuty (PD) has drawn attention after a recent price slide, with the stock down over the past week, month and past 3 months. This has raised questions about how its fundamentals line up against current investor sentiment. See our latest analysis for PagerDuty. At a share price of $11.22, PagerDuty’s recent 1 day, 7 day and 90 day share price returns of 5.08%, 9.08% and 29.12% declines align with a weaker 1 year total shareholder return of 38.69% and a 5 year total shareholder return of...